Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count Article

publication date

  • May 1, 2022

webpage

keywords

  • AERD
  • Asthma
  • biologic therapy
  • blood eosinophils
  • chronic rhinosinusitis
  • mepolizumab
  • nasal polyps
  • sinus surgery
  • type 2 inflammation

start page

  • 1711

end page

  • +

volume

  • 149

issue

  • 5